Prevention of Stroke and Dementia in Primary Care

NCT01107548 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3908

Last updated 2012-02-20

No results posted yet for this study

Summary

In Western Countries, stroke and dementia are the main causes of long-term disability, dependency, and nursing home admission. Due to demographic trends a continuous increase of patient numbers can be expected.

There is growing evidence that vascular risk factors which are implicated in the etiology of stroke also play important etiologic roles in both vascular dementia and Alzheimer disease. The present project is aimed at the reduction of stroke and dementia by means of a systematic detection and subsequent treatment of vascular risk factors by the family doctor based on established guidelines.

Conditions

Interventions

OTHER

Systematic detection of vascular risk factors and subsequent evidence-based treatment

Sponsors & Collaborators

  • AOK Bayern

    collaborator INDUSTRY
  • Stiftung Deutsche Schlaganfall-Hilfe

    collaborator UNKNOWN
  • Ratiopharm GmbH

    collaborator INDUSTRY
  • Sanofi-Synthelabo

    collaborator INDUSTRY
  • Organon

    collaborator INDUSTRY
  • Teva Pharma GmbH

    collaborator INDUSTRY
  • Bayer

    collaborator INDUSTRY
  • Berlin-Chemie Menarini

    collaborator INDUSTRY
  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Horst Bickel, PhD · Dept. of Psychiatry, Technical University of Munich

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-01-31
Primary Completion
2008-12-31
Completion
2010-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01107548 on ClinicalTrials.gov